Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing oxycodone/naloxone to oxycodone (OxyContin) in Korean cancer patients has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• OXYCONTIN (OXYCODONE HYDROCHLORIDE)
• Oxycodone/Naloxone (oxycodone/naloxone)

Snippet

Sponsor: Mundipharma Korea Ltd | Conditions: Cancer | Phase 4 | Status: COMPLETED | Results posted: 2016-10-27